Suppliers / Tiofarma

Tiofarma

Netherlands 395 employees Updated 9 July 2026

Tiofarma is a finished-dose manufacturer based in Netherlands. It appears in 82 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, FAMHP (BE) and MPA (SE). Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 22 September 2023 as NAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
82
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 22 September 2023 NAI US FDA
  • 6 July 2021 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Netherlands, Netherlands 3013984264
Oud-Beijerland, Netherlands Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 45 1
FAMHP (BE) 14 None
MPA (SE) 7 None
BFARM (DE) 5 None
DMP (NO) 4 None
INFARMED (PT) 2 None
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Tiofarma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 22 September 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates